JUL 16, 2019 3:18 AM PDT

Rare Bone Marrow Manifestation in Sarcoidosis

WRITTEN BY: Dena Aruta

Sarcoidosis is an inflammatory disease with the hallmark diagnostic feature being non-caseating granulomas--clumps of immune cells including macrophages, epithelial cells, and histiocytes. While 90% of people diagnosed with sarcoidosis have it in their lungs, the disease can affect any organ system in the body. Common extrapulmonary sites include skin, liver, eyes, and lymph nodes. The incidence in the U.S. is approximately is 10 per 100,000 people. The principal investigator, J. Isaac Peña-Garcia, and colleagues, discuss a case study involving a rare manifestation of sarcoidosis in the bone marrow. 

Bone marrow sarcoidosis (BMS) has not been described frequently in the literature. Peña-Garcia cites several studies that illustrate the wide variation in age, gender, and ethnicity, which is common in the involvement of other extrathoracic organs. In a prospective cohort study in which the participants were 95.8% Caucasian, 640 patients were followed over 40 years. None had bone marrow manifestations initially, and at follow up, only 0.3% had BMS. In contrast, in the  ACCESS (A Case-Control Etiologic Study of Sarcoidosis) study, there were 640 patients, of which 44% were African Americans, and 3.9% had BMS. 

In this case study, Peña-Garcia describes a 51-year-old African American woman with a previous diagnosis of cutaneous sarcoidosis. She presented with bilateral knee and lower leg pain as well as paresthesias without neurological involvement. She also had a "low-grade fever, hyporexia with an unintentional 30-pound weight loss over two years, and chronic dry cough." Among the numerous tests performed, a peripheral blood smear showed leukocytopenia and decreased red blood cells. The bone marrow biopsy showed normal cell lineage and non-caseating granulomas consistent with sarcoidosis.

The authors created an algorithm to follow when sarcoidosis patients present with decreased white blood cells and anemia:

Figure 1. A proposed approach to patient with sarcoidosis presenting with cytopenias. Credit  Peña-Garcia et al.

There have been no RCTs that compare different treatments, and to date, no FDA-approved treatment strategies for BMS, but prednisone is the gold standard for treatment of other forms of sarcoidosis. Methotrexate, which is used as a steroid-sparing medication, cannot be used in BMS due to its cytotoxic properties.

 

About the Author
BS Biology/Chemistry
After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
MAY 08, 2022
Technology
Detecting Cytokine Storm Through Sweat
MAY 08, 2022
Detecting Cytokine Storm Through Sweat
A cytokine storm is a severe immune system reaction where the body is flooded with cells and molecules (called cytokines ...
MAY 13, 2022
Drug Discovery & Development
Opioid Addiction Treatments Minimize Fetal Brain Changes
MAY 13, 2022
Opioid Addiction Treatments Minimize Fetal Brain Changes
The rise in opioid use, addiction, and overdose is a serious public health matter. Almost 850,000 people have died of dr ...
MAY 16, 2022
Technology
An Implantable Vascular Monitoring Device
MAY 16, 2022
An Implantable Vascular Monitoring Device
Vascular diseases are one of the most common causes of death around the globe. Encompassing a range of conditions (such ...
MAY 19, 2022
Drug Discovery & Development
Vaccine for Deadly Mosquito-borne Virus Shows Promising Trial Results
MAY 19, 2022
Vaccine for Deadly Mosquito-borne Virus Shows Promising Trial Results
Eastern equine encephalitis virus (EEEV), Western equine encephalitis (WEEV), Venezuelan equine encephalitis (VEEV) are ...
MAY 19, 2022
Drug Discovery & Development
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
MAY 19, 2022
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
An antibiotic known as clofoctol has shown promise in treating SARS-CoV-2 in mice. The corresponding study was published ...
MAY 20, 2022
Neuroscience
Suppressing Negative Memories Makes Them Fade Away
MAY 20, 2022
Suppressing Negative Memories Makes Them Fade Away
Actively suppressing negative experiences may help prevent intrusive thoughts and rumination. The corresponding study wa ...
Loading Comments...